Mercado de Polymarket
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Proximo
- Probabilidad
- Unavailable
Outcomes
Resultados del mercado
Precio en vivo
Precio y liquidez
Compra, venta, punto medio, spread y profundidad actuales para este resultado.
- Mejor compra
- Unavailable
- Mejor venta
- Unavailable
- Punto medio
- Unavailable
- Spread
- Unavailable
- Ultimo trade
- Unavailable
- Profundidad
- No disponible
Historial de precios
Esperando historial de precios
Historial no disponible
Compras
| Precio | Tamano |
|---|
Ventas
| Precio | Tamano |
|---|
Trades
Trades recientes
Latest visible trades for this market.
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 5 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 3,021 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 424.6 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 5 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 3,350.5 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 249 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 10 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 5 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 99.9% 197 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 98% 195.5 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 98% 1,500 shares
- FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?Yes 97.9% 3,609.5 shares